Literature DB >> 22206847

Synaptic protein deficits are associated with dementia irrespective of extreme old age.

Michal Schnaider Beeri1, Vahram Haroutunian, James Schmeidler, Mary Sano, Peter Fam, Aaron Kavanaugh, Alasdair M Barr, William G Honer, Pavel Katsel.   

Abstract

Recent evidence shows that despite high incidence of dementia in the very old, they exhibit significantly lower levels of Alzheimer's disease (AD) neuropathology relative to younger persons with dementia. The levels and distributions of some synaptic proteins have been found to be associated with dementia severity, even in the oldest-old, but the molecular and functional nature of these deficits have not been studied in detail. The objective of this study was to assess the relationship of dementia with gene and protein expression of a panel of synaptic markers associated with different synaptic functions in young-, middle-, and oldest-old individuals. The protein and messenger RNA (mRNA) levels of 7 synaptic markers (complexin-1, complexin-2, synaptophysin, synaptobrevin, syntaxin, synaptosomal-associated protein 25 (SNAP-25), and septin-5) were compared in the brains of nondemented and demented individuals ranging from 70 to 103 years of age. One hundred eleven brains were selected to have either no significant neuropathology or only AD-associated pathology (neuritic plaques [NPs] and neurofibrillary tangles [NFTs]). The cohort was then stratified into tertiles as young-old (70-81 years old), middle-old (82-88), and oldest-old (89-103). The brains of persons with dementia evidenced significantly lower levels of gene and protein expression of synaptic markers regardless of age. Importantly, dementia was associated with reductions in all measured synaptic markers irrespective of their role(s) in synaptic function. Although other dementia-associated hallmarks of AD neuropathology (neuritic plaques and neurofibrillary tangles) become less prominent with increasing age, synaptic marker abnormalities in dementia remain constant with increasing age and may represent an independent substrate of dementia spanning all ages.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22206847      PMCID: PMC3318958          DOI: 10.1016/j.neurobiolaging.2011.08.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  49 in total

1.  Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness.

Authors:  William G Honer; Peter Falkai; Thomas A Bayer; Jane Xie; Lily Hu; Hong-Ying Li; Victoria Arango; J John Mann; Andrew J Dwork; William S Trimble
Journal:  Cereb Cortex       Date:  2002-04       Impact factor: 5.357

Review 2.  Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals.

Authors:  William G Honer
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

3.  Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness.

Authors:  K Sawada; C E Young; A M Barr; K Longworth; S Takahashi; V Arango; J J Mann; A J Dwork; P Falkai; A G Phillips; W G Honer
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

4.  Afferent cortical connections and architectonics of the superior temporal sulcus and surrounding cortex in the rhesus monkey.

Authors:  B Seltzer; D N Pandya
Journal:  Brain Res       Date:  1978-06-23       Impact factor: 3.252

Review 5.  Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders.

Authors:  Mark P Mattson; Dong Liu
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

6.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

7.  Abnormalities of presynaptic protein CDCrel-1 in striatum of rats reared in social isolation: relevance to neural connectivity in schizophrenia.

Authors:  Alasdair M Barr; Clint E Young; Ken Sawada; William S Trimble; Anthony G Phillips; William G Honer
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

8.  Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease.

Authors:  Michael Serby; Adam M Brickman; Vahram Haroutunian; Dushyant P Purohit; Deborah Marin; Melinda Lantz; Richard C Mohs; Kenneth L Davis
Journal:  Am J Geriatr Psychiatry       Date:  2003 May-Jun       Impact factor: 4.105

9.  Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.

Authors:  Marianne J Engelhart; Mirjam I Geerlings; John Meijer; Amanda Kiliaan; Annemieke Ruitenberg; John C van Swieten; Theo Stijnen; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  Arch Neurol       Date:  2004-05

10.  Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele.

Authors:  Rebecca West; Michal Schnaider Beeri; James Schmeidler; Christine M Hannigan; Gary Angelo; Hillel T Grossman; Clive Rosendorff; Jeremy M Silverman
Journal:  Am J Geriatr Psychiatry       Date:  2008-09       Impact factor: 4.105

View more
  15 in total

1.  SNAP-25a/b Isoform Levels in Human Brain Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex.

Authors:  Peter M Thompson; Dianne A Cruz; Elizabeth A Fucich; Dianna Y Olukotun; Masami Takahashi; Makoto Itakura
Journal:  Mol Neuropsychiatry       Date:  2015-12-01

Review 2.  Cognitive and social lifestyle: links with neuropathology and cognition in late life.

Authors:  David A Bennett; Steven E Arnold; Michael J Valenzuela; Carol Brayne; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2013-12-20       Impact factor: 17.088

3.  Deconstructing complexin function in activating and clamping Ca2+-triggered exocytosis by comparing knockout and knockdown phenotypes.

Authors:  Xiaofei Yang; Peng Cao; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

4.  Chronic adjunction of 1-deoxynojirimycin protects from age-related behavioral and biochemical changes in the SAMP8 mice.

Authors:  Gui-Hai Chen; Jing-Jing Tong; Fang Wang; Xue-Qin Hu; Xue-Wei Li; Fei Tao; Zhao-Jun Wei
Journal:  Age (Dordr)       Date:  2015-09-23

5.  Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.

Authors:  John L Robinson; Laura Molina-Porcel; Maria M Corrada; Kevin Raible; Edward B Lee; Virginia M-Y Lee; Claudia H Kawas; John Q Trojanowski
Journal:  Brain       Date:  2014-07-09       Impact factor: 13.501

Review 6.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease.

Authors:  Juan Jose Ramos-Rodriguez; Tara Spires-Jones; Amy M Pooler; Alfonso Maria Lechuga-Sancho; Brian J Bacskai; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2016-05-14       Impact factor: 5.590

8.  Cognitive decline and dementia in the oldest-old.

Authors:  Efrat Kravitz; James Schmeidler; Michal Schnaider Beeri
Journal:  Rambam Maimonides Med J       Date:  2012-10-31

Review 9.  Neuropathological approaches to cerebral aging and neuroplasticity.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Dialogues Clin Neurosci       Date:  2013-03       Impact factor: 5.986

10.  Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer's disease at various cognitive stages.

Authors:  Odile Poirel; Sébastien Mella; Catherine Videau; Lauriane Ramet; Maria Antonietta Davoli; Etienne Herzog; Pavel Katsel; Naguib Mechawar; Vahram Haroutunian; Jacques Epelbaum; Stéphanie Daumas; Salah El Mestikawy
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.